UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice

The Journal of neuroscience, 2008-06, Vol.28 (25), p.6333-6341

2008

Volltextzugriff (PDF)

Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions

Journal of neuroinflammation, 2010-12, Vol.7 (1), p.95-95, Article 95

2010

Volltextzugriff (PDF)

Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions

Neuropathology and applied neurobiology, 2014-08, Vol.40 (5), p.564-578

2014

Volltextzugriff (PDF)

Minocycline affects microglia activation, Aβ deposition, and behavior in APP-tg mice

Glia, 2006-05, Vol.53 (7), p.776-782

2006

Volltextzugriff (PDF)

Validity and Reliability of the 32-Item Motor Function Measure in 2- to 5-Year-Olds with Neuromuscular Disorders and 2- to 25-Year-Olds with Spinal Muscular Atrophy

Neurology and therapy, 2020-12, Vol.9 (2), p.575-584

2020

Volltextzugriff (PDF)

Natural history of Type 2 and 3 spinal muscular atrophy: 2‐year NatHis‐SMA study

Annals of clinical and translational neurology, 2021-02, Vol.8 (2), p.359-373

2021

Volltextzugriff (PDF)

Short Amyloid-β (Aβ) Immunogens Reduce Cerebral Aβ Load and Learning Deficits in an Alzheimer's Disease Mouse Model in the Absence of an Aβ-Specific Cellular Immune Response

The Journal of neuroscience, 2006-05, Vol.26 (18), p.4717-4728

2006

Volltextzugriff (PDF)

Alzheimer's Disease Aβ Vaccine Reduces Central Nervous System Aβ Levels in a Non-Human Primate, the Caribbean Vervet

The American journal of pathology, 2004-07, Vol.165 (1), p.283-297

2004

Volltextzugriff (PDF)

Osteopetrotic (op/op) mice have reduced microglia, no Aβ deposition, and no changes in dopaminergic neurons

Journal of neuroinflammation, 2007-12, Vol.4 (1), p.31-31, Article 31

2007

Volltextzugriff (PDF)

Dendrimeric Aβ1–15 is an effective immunogen in wildtype and APP-tg mice

Neurobiology of aging, 2007-06, Vol.28 (6), p.813-823

2007

Volltextzugriff (PDF)

Novel Aβ Immunogens: Is Shorter Better?

Current Alzheimer research, 2007-09, Vol.4 (4), p.427-436

2007

Volltextzugriff (PDF)

Dendrimeric A beta 1-15 is an effective immunogen in wildtype and APP-tg mice

Neurobiology of aging, 2007-06, Vol.28 (6), p.813-823

2007

Volltextzugriff (PDF)

The effect of FTY720 in the Theiler's virus model of multiple sclerosis

Journal of the neurological sciences, 2011-09, Vol.308 (1), p.41-48

2011

Volltextzugriff (PDF)

Boosting with intranasal dendrimeric Aβ1–15 but not Aβ1–15 peptide leads to an effective immune response following a single injection of Aβ1–40/42 in APP-tg mice

Journal of neuroinflammation, 2006-06, Vol.3 (1), p.14-14, Article 14

2006

Volltextzugriff (PDF)

Risdiplam in Type 1 Spinal Muscular Atrophy

The New England journal of medicine, 2021-03, Vol.384 (10), p.915-923

2021

Volltextzugriff (PDF)

Modulation of the humoral and cellular immune response in Aβ immunotherapy by the adjuvants monophosphoryl lipid A (MPL), cholera toxin B subunit (CTB) and E. coli enterotoxin LT(R192G)

Vaccine, 2005-10, Vol.23 (44), p.5149-5159

2005

Volltextzugriff (PDF)

Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: lessons from mice, monkeys, and humans

Rejuvenation research, 2006-03, Vol.9 (1), p.77-84

2006

Volltextzugriff (PDF)

Basic Cyber Hygiene: Does It Work?

Computer (Long Beach, Calif.), 2019-04, Vol.52 (4), p.21-31

2019

Volltextzugriff (PDF)

Developing Novel Immunogens for an Effective, Safe Alzheimer’s Disease Vaccine

Neuro-degenerative diseases, 2005-01, Vol.2 (5), p.267-272

2005

Volltextzugriff (PDF)

Species-specific immune response to immunization with human versus rodent Aβ peptide

Neurobiology of aging, 2004-10, Vol.25 (9), p.1141-1151

2004

Volltextzugriff (PDF)

Differences in the immune response to long term Aβ vaccination in C57BL/6 and B6D2F1 mice

Vaccine, 2004-09, Vol.22 (29), p.4075-4083

2004

Volltextzugriff (PDF)

FIREFISH Part 1: 1-Year Results on Motor Function in Babies with Type 1 SMA (S25.003)

Neurology, 2019-04, Vol.92 (15_supplement)

2019

Volltextzugriff (PDF)

FIREFISH Part 1: Survival, Ventilation and Swallowing Ability in Infants with Type 1 SMA Receiving Risdiplam (RG7916) (S25.008)

Neurology, 2019-04, Vol.92 (15_supplement)

2019

Volltextzugriff (PDF)

Natural History of Type 2 and 3 Spinal Muscular Atrophy (SMA): Longitudinal 2-year NatHis-SMA Study (530)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Englisch
(76)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(38)
Humans
(28)
Animals
(24)
Biological And Medical Sciences
(17)
Neurosciences & Neurology
(17)
Neurosciences
(16)
Male
(15)
Mice
(15)
Female
(14)
Medical Sciences
(13)
Alzheimer's Disease
(11)
Neurology
(10)
Amyloid Beta-Peptides - Immunology
(9)
Mice, Transgenic
(8)
Pediatrics
(8)
Alzheimer Disease - Prevention & Control
(6)
Clinical Neurology
(6)
Disease Models, Animal
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice

Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions

Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study

Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions

Minocycline affects microglia activation, Aβ deposition, and behavior in APP-tg mice

Validity and Reliability of the 32-Item Motor Function Measure in 2- to 5-Year-Olds with Neuromuscular Disorders and 2- to 25-Year-Olds with Spinal Muscular Atrophy

Natural history of Type 2 and 3 spinal muscular atrophy: 2‐year NatHis‐SMA study

Short Amyloid-β (Aβ) Immunogens Reduce Cerebral Aβ Load and Learning Deficits in an Alzheimer's Disease Mouse Model in the Absence of an Aβ-Specific Cellular Immune Response

Alzheimer's Disease Aβ Vaccine Reduces Central Nervous System Aβ Levels in a Non-Human Primate, the Caribbean Vervet

Osteopetrotic (op/op) mice have reduced microglia, no Aβ deposition, and no changes in dopaminergic neurons

Dendrimeric Aβ1–15 is an effective immunogen in wildtype and APP-tg mice

Novel Aβ Immunogens: Is Shorter Better?

Dendrimeric A beta 1-15 is an effective immunogen in wildtype and APP-tg mice

The effect of FTY720 in the Theiler's virus model of multiple sclerosis

Boosting with intranasal dendrimeric Aβ1–15 but not Aβ1–15 peptide leads to an effective immune response following a single injection of Aβ1–40/42 in APP-tg mice

Risdiplam in Type 1 Spinal Muscular Atrophy

Modulation of the humoral and cellular immune response in Aβ immunotherapy by the adjuvants monophosphoryl lipid A (MPL), cholera toxin B subunit (CTB) and E. coli enterotoxin LT(R192G)

Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: lessons from mice, monkeys, and humans

Basic Cyber Hygiene: Does It Work?

Developing Novel Immunogens for an Effective, Safe Alzheimer’s Disease Vaccine

Species-specific immune response to immunization with human versus rodent Aβ peptide

Differences in the immune response to long term Aβ vaccination in C57BL/6 and B6D2F1 mice

FIREFISH Part 1: 1-Year Results on Motor Function in Babies with Type 1 SMA (S25.003)

FIREFISH Part 1: Survival, Ventilation and Swallowing Ability in Infants with Type 1 SMA Receiving Risdiplam (RG7916) (S25.008)

Natural History of Type 2 and 3 Spinal Muscular Atrophy (SMA): Longitudinal 2-year NatHis-SMA Study (530)

Suchergebnisse filtern